Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multicentric Castleman Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01024036
What this trial is testing

Evaluate the Efficacy and Safety of CNTO328 Plus Best Supportive Care in Multicentric Castleman's Disease

Who this might be right for
Multicentric Castleman's Disease
Janssen Research & Development, LLC 79
Not applicableLooking for participantsNCT07793006
What this trial is testing

New Approaches for the Diagnosis of Lymphoma and Multicentric Castleman Disease

Who this might be right for
HIVKaposi Sarcoma Herpesvirus -Associated Multicentric Castleman DiseaseHodgkin Lymphoma+3 more
Indiana University 500
Not applicableStudy completedNCT02853968
What this trial is testing

Unlock the Cell: Castleman's Disease Flow Cytometry Study

Who this might be right for
Castleman DiseaseAngiofollicular Lymphoid HyperplasiaGLNH+4 more
University of Pennsylvania 130
Testing effectiveness (Phase 2)UnknownNCT04743687
What this trial is testing

Zanuburutinib in Relapsed and Refractory iMCD: a Prospective, Single-center, Single-arm Trial

Who this might be right for
Idiopathic Multicentric Castleman's Disease
Peking Union Medical College Hospital 30
Testing effectiveness (Phase 2)UnknownNCT03982771
What this trial is testing

BCD Regimen in Newly Diagnosed Idiopathic Multicentric Castleman's Disease (iMCD)

Who this might be right for
Idiopathic Multicentric Castleman's Disease
Peking Union Medical College Hospital 30
Early research (Phase 1)Ended earlyNCT03864419
What this trial is testing

Rituximab Hyaluronidase in Combination With Chemotherapy in Treating Aggressive B-cell Lymphoma in Uganda

Who this might be right for
Burkitt LymphomaKSHV-associated Multicentric Castleman DiseaseDiffuse Large B-Cell Lymphoma
Fred Hutchinson Cancer Center 18
Post-approval studies (Phase 4)WithdrawnNCT00361933
What this trial is testing

Valganciclovir to Treat HHV-8 Associated Multicentric Castleman's Disease

Who this might be right for
Giant Lymph Node Hyperplasia
University of Washington
Testing effectiveness (Phase 2)WithdrawnNCT02228512
What this trial is testing

Study of Pomalidomide Combined With Modified DA-EPOCH and Rituximab in KSHV-Associated Lymphomas

Who this might be right for
Large Cell Lymphoma Arising in KSHV-associated Multicentric Castleman DiseasePrimary Effusion Lymphoma
National Cancer Institute (NCI)
Not applicableLooking for participantsNCT05663502
What this trial is testing

Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers

Who this might be right for
Anal CarcinomaHematopoietic and Lymphoid Cell NeoplasmHIV Infection+9 more
AIDS Malignancy Consortium 200
Not applicableLooking for participantsNCT04968288
What this trial is testing

Natural History of KSHV-Associated Multicentric Castleman s Disease

Who this might be right for
Multicentric Castleman s Disease
National Cancer Institute (NCI) 195
Testing effectiveness (Phase 2)Active Not RecruitingNCT03933904
What this trial is testing

Sirolimus in Previously Treated Idiopathic Multicentric Castleman Disease

Who this might be right for
Castleman DiseaseCastleman's Disease, Multicentric
University of Pennsylvania 7
Not applicableLooking for participantsNCT02817997
What this trial is testing

International Registry for Patients With Castleman Disease

Who this might be right for
Castleman DiseaseCastleman's DiseaseGiant Lymph Node Hyperplasia+6 more
University of Pennsylvania 1,000